Hoppa direkt till innehållet
Huvudmenyn dold.

Bethany van Guelpen

Forskargrupp Risk profiling and early detection of colorectal cancer.

Colorectal cancer (CRC), the third most common cancer in men and women in Sweden and, if discovered early, prognosis is good. However, despite considerable therapeutic advances in recent decades, the prognosis for advanced CRC is markedly worse. Effective strategies for the prevention and early detection of CRC therefore have great potential to substantially reduce the overall societal burden of this disease.

Colonoscopy is the gold standard for CRC detection. But does everyone really need this uncomfortable and invasive procedure? What if it was possible to use less invasive methods to identify individuals at high risk of developing CRC, or with asymptomatic premalignant or early malignant lesions? Improving risk profiling to allow selection of individuals with the most to win from preventive strategies and colonoscopy screening is a major challenge in CRC research today and the main purpose of Bethany Van Guelpen's research.

Bethany Van Guelpen's research has an integrative molecular epidemiology approach, using extensive health and lifestyle data and prospectively collected blood samples from the large, population-based cohorts in northern Sweden, archival tumor tissue from CRC cases in the same cohorts, broad OMICS technologies and advanced statistical analyses.

One main research question, funded by the Swedish Cancer Society (Cancerfonden), is the potentially different role of lifestyle-related factors in subtypes of CRC based on particular traits, or combinations of traits, in the tumor. The lifestyle-related factors include: 1. factors involved in one-carbon metabolism, e.g. plasma folate levels, 2. factors involved in energy metabolism, e.g. body constitution and fasting blood glucose levels, and 3. factors involved in inflammation, e.g. diet and inflammatory markers.

A unique set of longitudinally collected blood samples, taken 10 years apart, in approximately 70 CRC cases and 1:1 time-matched control subjects has also been selected from the same cohorts. Epigenomic, targeted proteomic and metabolomic methods are currently being applied to search for biomarkers of CRC or high CRC risk. Results from the discovery phase will then be validated in larger study sets. The CRC subtype and biomarker results will also be compared and integrated, to provide further etiological insights.

Combining blood-based biomarkers with refined risk profiling for personalized CRC prevention and targeted colonoscopy screening has the potential to reduce CRC incidence and mortality.


Bethany van Guelpen
Biträdande universitetslektor, ST-läkare, övrig/annan befattning
090-785 28 09


Medverkande institutioner och enheter vid Umeå universitet

Institutionen för strålningsvetenskaper




Antibiotika ökar risk för cancer i tjocktarmen

Tydligt samband upptäckt mellan att äta antibiotika och ökad risk att drabbas av cancer i tjocktarmen.

NMMP medel för samarbetsprojekt med SciLifeLab

Ett mindre anslag öppnar dörren för nationellt samarbete mellan unga gruppledare vid WCMM och SciLifeLab.


Cancer Epidemiology, Biomarkers and Prevention, Elsevier 2021, Vol. 30, (3) : 564-575
Nounu, Aayah; Greenhough, Alexander; Heesom, Kate J.; et al.
Clinical Gastroenterology and Hepatology
Papadimitriou, Nikos; Bouras, Emmanouil; van den Brandt, Piet A.; et al.
Scientific Reports, Springer Nature 2021, Vol. 11, (1)
Harlid, Sophia; Harbs, Justin; Myte, Robin; et al.
Clinical Nutrition, Elsevier 2021, Vol. 40, (6) : 3772-3779
Iguacel, Isabel; Schmidt, Julie A.; Perez-Cornago, Aurora; et al.
Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research (AACR) 2021, Vol. 30, (5) : 953-964
Dimou, Niki; Yarmolinsky, James; Bouras, Emmanouil; et al.
Clinical Nutrition, Elsevier 2021, Vol. 40, (9) : 5079-5088
Cordova, Reynalda; Kliemann, Nathalie; Huybrechts, Inge; et al.
BMC Medicine, BioMed Central 2021, Vol. 19, (1)
Aleksandrova, Krasimira; Reichmann, Robin; Kaaks, Rudolf; et al.
Komplext samband mellan kost och cancer

Att inflammation skulle vara huvudsakorsak till sambandet mellan mat och cancer, kunde inte bekräftas.

Nya Cancerfondsmiljoner till forskning i Umeå

Cancerfonden har beslutat att bevilja 57 miljoner kronor till cancerforskning vid Umeå universitet

NMMP medel för samarbetsprojekt med SciLifeLab

Ett mindre anslag öppnar dörren för nationellt samarbete mellan unga gruppledare vid WCMM och SciLifeLab.